Effects of pH-sensitive nanoparticles prepared with different polymers on the distribution, adhesion and transition of Rhodamine 6G in the gut of rats

Journal of Microencapsulation

Volumn 27, Issue 3, 2010, Pages 205-217

  Wu, Cui Shuan ^a   Wang, Xue Qing ^a   Meng, Meng ^a   Li, Ming Guang ^a   Zhang, Hua ^a   Zhang, Xuan ^a   Wang, Jian Cheng ^a   Wu, Tao ^b   Nie, Wen Hui ^b   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Institute of Double Crane   (China)

Author keywords

Adhesion; Distribution; Enteric polymers; Gastrointestinal tract; PH sensitive nanoparticles; Transition

Indexed keywords

EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; NANOCARRIER; POLOXAMER; RHODAMINE 6G;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CECUM; COLON; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG RELEASE; DRUG SOLUBILITY; DUODENUM; ENTERIC COATED TABLET; ILEUM; INTESTINE TRANSIT TIME; JEJUNUM; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; RAT; STOMACH; STOMACH EMPTYING;

ANIMALS; DRUG CARRIERS; GASTROINTESTINAL TRACT; HYDROGEN-ION CONCENTRATION; MALE; NANOPARTICLES; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINES;

EID: 77951437700     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040903059163     Document Type: Article

References (28)

1. Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative. Pharm Res. 1995;12:397-405.
2. Arbó P, Campanero MA, Arangoa MA, Renedo MJ, Irache JM. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J Contr Rel. 2003;89:19-30.
3. Arifin DY, Lee LY, Wang C-H. Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Del Rev. 2006;58:1274-1325.
4. Dai J, Nagai T, Wang X, Zhang T, Meng M, Zhang Q. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm. 2004;280:229-240. (Pubitemid 38950919)
5. Davis SS. Formulation strategies for absorption windows. Drug Disc Today. 2005;10:249-257.
6. De Jaeghere F, Alléann E, Kubel F, Galli B, Cozens R, Doelker E, Gurny R. Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J Contr Rel. 2000;68:291-298.
7. Deng Z, Xu S, Li S. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications. Int J Pharm. 2008; 351:236-243.
8. Florence AT. Nanoparticle uptake by the oral route: fulfilling its potential?. Drug Disc Today Technol. 2005;2:75-81.
9. Hanafy A, Spahn-Langguth H, Vergnault G, Grenier P, Tubic Grozdanis M, Lenhardt T, Langguth P. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Del Rev. 2007;59:419-426.
10. Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh K. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J Pharm Sci. 1989;78:68-72.
11. Kim M-S, Jin S-J, Kim J-S, Park HJ, Song H-S, Neubert RHH, Hwang S-J. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 2008;69:454-465.
12. Lahnstein K, Schmehl T, Rusch U, Rieger M, Seeger W, Gessler T. Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung. Int J Pharm. 2008;351:158-164.
13. Lamprecht A, Schafer U, Lehr CM. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res. 2001;18:788-793.
14. Lee J. Drug nano- and microparticles processed into solid dosage forms: physical properties. J Pharm Sci. 2003;92:2057-2068.
15. Leroux JC, Cozens R, Roesel JL, Galli B, Kubel F, Doelker E, Gurny R. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or biodegradable or enteric nanoparticles s following intravenous and oral administration to mice. J Pharm Sci. 1995;84:1387-1391.
16. Leroux JC, Cozens RM, Roesel JL, Galli B, Doelker E, Gurny R. pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs. Pharm Res. 1996;13:485-487. (Pubitemid 26114733)
17. Li M-G, Lu W-L, Wang J-C, Zhang X, Wang X-Q, Zheng A-P, Zhang Q. Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. Int J Pharm. 2007;329:182-191.
18. McDowell A, McLeod BJ. Physiology and pharmacology of the brushtail possum gastrointestinal tract: relationship to the human gastrointestinal tract. Adv Drug Del Rev. 2007;59:1121-1132.
19. Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol. 2008;36: 43-48.
20. Rhowe RC, Sheskey PJ, Weller PJ, Zheng J-M. Handbook of pharmaceutical Excipients. Beijing Chemical Industry Press; 2004.
21. Sakuma S, Ogura R, Sakuma S, Ogura R, Masaoka Y, Kataoka M, Tanno FK, Kokubo H, Yamashita S. Correlation between in vitro dissolution profiles from enteric-coated dosage forms and in vivo absorption in rats for high-solubility and high-permeability model drugs. Journal of pharmaceutical sciences. 2009; www.interscience.wiley.com.2009. DOI: 10.1002/jps.21716.
22. Shekunov BY, Chattopadhyay P, Seitzinger J, Huff R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm Res. 2006;23:196-204.
23. Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Contr Rel. 2004;98:231-244.
24. Wang XQ, Dai JD, Chen Z, Zhang T, Xia GM, Nagai T, Zhang Q. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J Contr Rel. 2004; 97:421-429. (Pubitemid 38802944)
25. Wang XQ, Dai JD, Zhang H, Zhang X, Wang JC, Zhang Q. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. J Nanosci Nanotechnol. 2008;8:2422-2431.
26. Watts PJ, Barrow L, Steed KP, Wilson CG, Spiller RC, Melia CD, Davies MC. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int J Pharm. 1992;87:215-221.
27. Yoncheva K, Guembe L, Campanero MA, Irache JM. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Int J Pharm. 2007;334:156-165.
28. Zhang Z, Feng SS. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials. 2006;27:262-270.